NEW YORK – Clayton, Dubilier & Rice will make a “significant equity investment” in Drive DeVilbiss Healthcare, the companies announced today.
CD&R will make the investment, “alongside existing management,” according to a press release.
SAN DIEGO – Will ResMed become the second major manufacturer to get a slap on the wrist from the government for its resupply program?
NEWPORT BEACH, Calif. – Cure Medical’s recent launch of the M14XL intermittent catheter, the longest available on the market today, is only the most recent example of how the company prioritizes end users.
From June 2015 to June 2016, Springfield, Pa.-based Apacheta, a mobile workflow application that’s integrated with Brightree, experienced a 120% increase in customers, primarily HME providers.
SAN DIEGO – ResMed in July received a federal administrative subpoena from the Office of Inspector General requesting documents and other information related to its patient resupply software.
PORT WASHINGTON, N.Y. – Drive Medical has sent a letter to its customers in response to reports that private equity firm Clayton, Dubilier & Rice is close to buying the company.
GOLETA, Calif. – The second quarter went so well for Inogen that the manufacturer and provider of portable oxygen concentrators has increased its guidance for the year.
PORT WASHINGTON, N.Y. – Buyout firm Clayton, Dubilier & Rice is in talks to buy Drive DeVilbiss for about $750 million, according to Reuters.
ELYRIA, Ohio – Invacare is holding tight to an improvement in gross margin for its beleaguered North America HME division as a sign that its turnaround efforts are paying off.
SAN DIEGO – ResMed invested $1 billion in acquisitions in fiscal year 2016. Now, the company is “laser focused” on getting a return on its investment, says CEO Mick Farrell.
Open Standard Media Player version 1.3
Supplies patients: Look at the 'market basket'
© 2016 United Publications Inc. ALL RIGHTS RESERVED